Treace Medical Concepts, Inc. (TMCI) stock
TMCINasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/3031% below fair value
$4.53+0.09 (+2.03%)
Close on Nov 18, 2026Market cap $294.61MP/E –Yield –
Treace Medical Concepts revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Treace Medical Concepts's revenue for the twelve months ending Jun 30, 2026 was $205.31M, down 4.0% year over year. For fiscal 2025 it was $212.69M, up 1.6% from the year before. The highest annual figure on record is $212.69M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $212.69M | +1.6% |
| FY2024 | Dec 31, 2024 | $209.36M | +11.9% |
| FY2023 | Dec 31, 2023 | $187.12M | +31.9% |
| FY2022 | Dec 31, 2022 | $141.84M | +50.2% |
| FY2021 | Dec 31, 2021 | $94.42M | +64.6% |
| FY2020 | Dec 31, 2020 | $57.37M | +45.5% |
| FY2019 | Dec 31, 2019 | $39.42M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $45.38M | -4.2% |
| Q1 FY2026 | Mar 31, 2026 | $47.20M | -10.2% |
| Q4 FY2025 | Dec 31, 2025 | $62.52M | -9.0% |
| Q3 FY2025 | Sep 30, 2025 | $50.21M | +11.4% |
| Q2 FY2025 | Jun 30, 2025 | $47.39M | +6.6% |
| Q1 FY2025 | Mar 31, 2025 | $52.57M | +2.9% |
| Q4 FY2024 | Dec 31, 2024 | $68.71M | +10.4% |
| Q3 FY2024 | Sep 30, 2024 | $45.09M | +10.6% |
| Q2 FY2024 | Jun 30, 2024 | $44.46M | +6.0% |
| Q1 FY2024 | Mar 31, 2024 | $51.11M | +21.1% |
| Q4 FY2023 | Dec 31, 2023 | $62.21M | +25.0% |
| Q3 FY2023 | Sep 30, 2023 | $40.76M | +23.3% |
| Q2 FY2023 | Jun 30, 2023 | $41.95M | +40.0% |
| Q1 FY2023 | Mar 31, 2023 | $42.20M | +45.3% |
| Q4 FY2022 | Dec 31, 2022 | $49.77M | +48.8% |
| Q3 FY2022 | Sep 30, 2022 | $33.06M | +52.9% |
| Q2 FY2022 | Jun 30, 2022 | $29.97M | +45.1% |
| Q1 FY2022 | Mar 31, 2022 | $29.05M | +55.3% |
| Q4 FY2021 | Dec 31, 2021 | $33.44M | +38.7% |
| Q3 FY2021 | Sep 30, 2021 | $21.62M | +51.5% |
| Q2 FY2021 | Jun 30, 2021 | $20.65M | +166.9% |
| Q1 FY2021 | Mar 31, 2021 | $18.71M | +66.2% |
| Q4 FY2020 | Dec 31, 2020 | $24.11M | – |
| Q3 FY2020 | Sep 30, 2020 | $14.27M | – |
| Q2 FY2020 | Jun 30, 2020 | $7.74M | – |
| Q1 FY2020 | Mar 31, 2020 | $11.26M | – |
See a number that looks wrong?